Vaklavas, C., & Forero-Torres, A. (2012). Safety and efficacy of brentuximab vedotin in patients with Hodgkin lymphoma or systemic anaplastic large cell lymphoma. SAGE Publications.
Citação norma ChicagoVaklavas, Christos, and Andres Forero-Torres. Safety and Efficacy of Brentuximab Vedotin in Patients With Hodgkin Lymphoma or Systemic Anaplastic Large Cell Lymphoma. SAGE Publications, 2012.
MLA CitationVaklavas, Christos, and Andres Forero-Torres. Safety and Efficacy of Brentuximab Vedotin in Patients With Hodgkin Lymphoma or Systemic Anaplastic Large Cell Lymphoma. SAGE Publications, 2012.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.